IPP Bureau
Novavax and SK bioscience expand manufacturing agreement
By IPP Bureau - December 24, 2021
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
Granules India appoints Sucharita Rao Palepu as Non-executive Independent Director
By IPP Bureau - December 24, 2021
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis
By IPP Bureau - December 24, 2021
Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000
Lecanemab granted Fast Track designation by the U.S. FDA
By IPP Bureau - December 24, 2021
Alzheimer's disease is a serious, progressive and devastating disease with few treatment options
CanSinoBio’s Convidecia vaccine largely effective against Covid-19 in phase III trial
By IPP Bureau - December 24, 2021
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
Study shows AstraZeneca’s Covid-19 booster dose protects against Omicron
By IPP Bureau - December 23, 2021
Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant
Pfizer’s Covid-19 pill gets U.S. FDA clearance
By IPP Bureau - December 23, 2021
Pfizer raises production projections from 80 million to 120 million courses of treatment in 2022, as a result of continued investments to support the manufacturing and distribution of Paxlovid
Evusheld neutralises Omicron in latest studies
By IPP Bureau - December 23, 2021
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
U.S. FDA grants De Novo Clearance for Philips IVC filter removal laser sheath
By IPP Bureau - December 23, 2021
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
Manipal Hospital Delhi opens advanced cancer care centre
By IPP Bureau - December 23, 2021
The hospital has recently launched Radionuclide therapy
U.S. FDA approves Novartis Leqvio to lower cholestrol
By IPP Bureau - December 23, 2021
With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1
Windlas Biotech appoints Shailendra Rastogi as CBO
By IPP Bureau - December 22, 2021
He has over 22 years of experience in pharmaceutical sales & business development
Piramal Pharma takes a minority stake in Yapan Bio
By IPP Bureau - December 22, 2021
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
By IPP Bureau - December 22, 2021
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Merck acquires Chord Therapeutics to expand its neuroinflammatory pipeline
By IPP Bureau - December 22, 2021
Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
